Aquatic Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,909
Closed -$512K 1382
2025
Q4
$512K Buy
+2,909
New +$475K 0.01% 727
2025
Q3
Sell
-2,792
Closed -$351K 1392
2025
Q2
$351K Sell
2,792
-32,440
-92% -$4.04M 0.01% 907
2025
Q1
$4.82M Sell
35,232
-29,713
-46% -$4.25M 0.12% 219
2024
Q4
$9.93M Buy
64,945
+10,845
+20% +$1.83M 0.27% 91
2024
Q3
$10.5M Buy
+54,100
New +$11.3M 0.27% 98
2024
Q2
Sell
-80,500
Closed -$17.4M 1242
2024
Q1
$17.4M Buy
80,500
+73,700
+1,084% +$17.3M 0.57% 44
2023
Q4
$1.76M Buy
6,800
+5,920
+673% +$1.45M 0.04% 359
2023
Q3
$226K Sell
880
-7,520
-90% -$2.01M 0.01% 652
2023
Q2
$2.39M Buy
+8,400
New +$2.5M 0.13% 173
2023
Q1
Sell
-34,700
Closed -$9.61M 1281
2022
Q4
$9.61M Buy
+34,700
New +$9.8M 0.7% 17
2022
Q3
Sell
-4,500
Closed -$918K 1189
2022
Q2
$918K Buy
+4,500
New +$920K 0.3% 89
2022
Q1
Sell
-1,200
Closed -$288K 1101
2021
Q4
$288K Buy
+1,200
New +$309K 0.56% 16

Other funds holding BIIB

Aquatic Capital Management's BIIB Position: Q1 2026 in Review

Aquatic Capital Management sold out of Biogen (BIIB) in Q1 2026, closing a stake of 2,909 shares — an estimated $512K sold.

Aquatic Capital Management first reported a position in BIIB in Q4 2021 and held it in 12 quarters. The position peaked at $17.4M in Q1 2024. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Aquatic Capital Management reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 2,909 Biogen shares in Q1 2026, an estimated $512K.
  • Aquatic Capital Management first reported a position in Biogen in Q4 2021 and held it in 12 quarters.
  • Aquatic Capital Management's Biogen position peaked at $17.4M in Q1 2024.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.